About
Chief Scientific Advisor
Professor Roger Kornberg
Roger D. Kornberg, Nobel Laureate in Chemistry (2006), is a celebrated figure in the scientific community, best known for his groundbreaking work on the molecular basis of eukaryotic transcription. Born in St. Louis, Missouri, into a family deeply rooted in biochemistry—his father, Arthur Kornberg, also won a Nobel Prize—Roger has continued this legacy with his own significant contributions to the field.
Kornberg’s journey in the sciences began with his education at Harvard University, where he earned his bachelor’s degree in chemistry in 1967. He furthered his studies at Stanford University, obtaining a Ph.D. in Physical Chemistry in 1972. His postdoctoral research took him to the Laboratory of Molecular Biology in Cambridge, England, and later to Harvard Medical School as an Assistant Professor of Biological Chemistry. In 1978, he joined Stanford Medical School as a Professor of Structural Biology, a position he still holds today.
His research has been pivotal in understanding the process of DNA transcription. He identified the role of RNA polymerase II and other proteins in this process and used X-ray crystallography to create three-dimensional images of these protein clusters. His discoveries extend to the “flip-flop” and lateral diffusion of phospholipids in bilayer membranes and the nucleosome’s role as a basic protein complex packaging chromosomal DNA in eukaryotic cells. Kornberg’s work with the nucleosome illuminated its function as a general gene repressor and its regulatory role in transcription.
Moreover, Kornberg’s lab at Stanford succeeded in developing a transcription system from baker’s yeast, which helped isolate the proteins required for the transcription process. His discovery of the Mediator complex was a milestone in understanding the transcription process in eukaryotic organisms.
Our Team
Hamutal Ben Dov, Ph.D.
Senior Scientist
Ylena Poliansky, DVM
Attending Veterinarian
Shira Bezaleli
Bookeeper & Salary Administrator
Board of Directors
Prof. Alon Dumanis, Chairman of the Board
Dr. Alon Dumanis, is the Chief Executive Officer of Dumanis Investments Ltd and its affiliates. He is currently a chairman of Aposense (TASE-APOS), a member of the board of directors of Nova Measuring Instruments (NASDAQ-NVMI) and Rada Electronic Industries (NASDAQ-RADA), Managing Partner of Augmentum Ltd., and CEO of ACS Air-Cyber Solutions Ltd. Dr. Dumanis was for 15 years (till 2015) the Chief Executive Officer of Docor International Management Ltd. and the General Manager of Crecor B.V. and Docor International B.V., Dutch investment companies, subsidiaries of The Van-Leer Group Foundation.
Mr. Jacob Gottenstein, Co-founder
Mr. Gottenstein is Chairman of the Board of Israel Petrochemical Enterprises and is a part of the controlling shareholders and a director in Israel’s Oil refineries limited (TASE: ORL). Mr. Gottenstein has a vast activity in different ventures in both industry, biotech and tech.
Dr. Morry Blumenfeld
Dr. Blumenfeld is a partner in Ziegler-Meditech Equity Partners and is a former medical imaging technology leader in GE Medical Systems, where for many years he led the technology development for GE’s CT and MRI business sectors.
Dr. Shlomo Segev
Dr. Shlomo Segev is the head of the Institute For Medical Screening at the Chaim Sheba Medical Center Tel-Hashomer. He served as the personal physician of three Israeli prime ministers, Yitzhak Rabin, Ariel Sharon and Ehud Olmert, as well as the personal physician of former President of Israel Shimon Peres. Dr. Shlomo Segev serves as a board member and medical advisor for various medical product companies and startups.
Mr. Amos Bar Shalev
Mr. Bar Shalev managed several VC Funds, and is on the board of Protalix, Twine, Ripples, PetNovations and others. He received his BSc from the Technion and MBA from Tel Aviv University.
Ms. Yael Vinokursky
Ms. Yael Vinokursky is the CFO of ID Federman Holdings Ltd and of the Modgal Group companies. She holds a BA in Economics and an MBA in Business Management, both from TA university.
Prof. Yehuda Adler, M.D, M.H.A
Director, Development of Medical Resources; Director, Talpiot Medical Leadership Program; Chairman, Sheba Internship Committee, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Mr. Eli Mandelberg
Mr. Mandelberg was an Executive VP for business development of Solel Solar Systems and Heliofocus. He is an independent consultant and Director at Tamuz Energy. Holds a BSc. In Mechanical engineering followed by business management studies – TA University.
Board of Directors
Prof. Alon Dumanis, Chairman of the Board
Prof. Alon Dumanis, is the Chief Executive Officer of Dumanis Investments Ltd and its affiliates. He is currently a chairman of Aposense (TASE-APOS), a member of the board of directors of Nova Measuring Instruments (NASDAQ-NVMI) and Rada Electronic Industries (NASDAQ-RADA), Managing Partner of Augmentum Ltd., and CEO of ACS Air-Cyber Solutions Ltd. Dr. Dumanis was for 15 years (till 2015) the Chief Executive Officer of Docor International Management Ltd. and the General Manager of Crecor B.V. and Docor International B.V., Dutch investment companies, subsidiaries of The Van-Leer Group Foundation.
Mr. Yaacov Gottenstein
Mr. Gottenstein is Chairman of the Board of Israel Petrochemical Enterprises (TASE: PTCH), and a co-founder of Aposense.
Dr. Morry Blumenfeld
Dr. Blumenfeld is a partner in Ziegler-Meditech Equity Partners, and is a former medical imaging technology leader in GE Medical Systems, where for many years he led the technology development for GE’s CT and MRI business sectors.
Dr. Joseph Dubrovsky
Dr. Blumenfeld is a partner in Ziegler-Meditech Equity Partners, and is a former medical imaging technology leader in GE Medical Systems, where for many years he led the technology development for GE’s CT and MRI business sectors.
Ms. Yael Vinokursky
Ms. Yael Vinokursky is the CFO of ID Federman Holdings Ltd and of the Modgal Group companies. She hold a BA in Economics and an MBA in Business Management, both from TA university
Mr. Amos Bar Shalev
Mr. Bar Shalev managed several VC Funds, and is on the board of Protalix, Twine, Ripples, PetNovations and others. He received his BSc from the Technion and MBA from Tel Aviv University.
Prof. Yehuda Adler, M.D, M.H.A
Director, Development of Medical Resources; Director, Talpiot Medical Leadership Program; Chairman, Sheba Internship Committee, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Mr. Eli Mandelberg
Mr. Mandelberg was an Executive VP for business development of Solel Solar Systems and Heliofocus. He is an Independent consultant and Director at Tamuz Energy. Holds a BSc. In Mechanical engineering followed by business management studies – TA University.
Ms. Michal Noy
Ms. Noy is an Advocate, holds an LLB from the Hebrew University of Jerusalem. , She is an Investment Banker of Israeli companies, in the fields of industry, finance and technology. She serves as a Board Member of several public companies.
Mr. Amos Mar-Haim
Mr. Amos Mar-Haim served as Director General at Israeli Ministry of Trade and Industry. Mr. Mar-Haim’s business career began in 1979 as a Director General of AML Corp. Ltd. and then of Clal Industries Ltd. From 1989 to 1994, Mr. Mar-Haim served as a Senior Deputy Mayor of Jerusalem and later as the Mayor of the city of Bnei-Brak.